Royal Bank of Canada
DARE icon

Royal Bank of Canada’s Dare Bioscience DARE Stock Holding History

Royal Bank of Canada’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
+59
New +$101 ﹤0.01% 7223
2024
Q1 		– Sell
-45
Closed – – 7106
2023
Q4 		$0 Buy
+45
New +$206 ﹤0.01% 7202
2023
Q3 		– Sell
-32
Closed – – 7164
2023
Q2 		$0 Buy
+32
New +$380 ﹤0.01% 7324
2022
Q4 		– Sell
-1
Closed – – 7308
2022
Q3 		$0 Buy
+1
New +$14 ﹤0.01% 7506
2021
Q3 		– Sell
-4
Closed – – 7662
2021
Q2 		$0 Buy
+4
New +$68 ﹤0.01% 7510
2018
Q4 		– Sell
-7
Closed – – 6816
2018
Q3 		$0 Hold
7
– – ﹤0.01% 6762
2018
Q2 		$0 Hold
7
– – ﹤0.01% 6566
2018
Q1 		$0 Hold
7
– – ﹤0.01% 6420
2017
Q4 		$0 Hold
7
– – ﹤0.01% 6598
2017
Q3 		$0 Sell
7
-8
-53% -$392 ﹤0.01% 6750
2017
Q2 		$1K Hold
15
– – ﹤0.01% 6377
2017
Q1 		$1K Hold
15
– – ﹤0.01% 6504
2016
Q4 		$1K Sell
15
-13
-46% -$1.24K ﹤0.01% 6545
2016
Q3 		$3K Sell
28
-16
-36% -$3.58K ﹤0.01% 6085
2016
Q2 		$11K Buy
44
+4
+10% +$1.28K ﹤0.01% 5720
2016
Q1 		$13K Hold
40
– – ﹤0.01% 5646
2015
Q4 		$13K Hold
40
– – ﹤0.01% 5877
2015
Q3 		$18K Hold
40
– – ﹤0.01% 5605
2015
Q2 		$22K Buy
40
+16
+67% +$11K ﹤0.01% 5639
2015
Q1 		$26K Buy
24
+16
+200% +$15.5K ﹤0.01% 5244
2014
Q4 		$6K Buy
+8
New +$4.99K ﹤0.01% 5748

Other funds holding DARE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada's DARE Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in Dare Bioscience (DARE) in Q1 2026: 59 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #7223 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in DARE as recently as Q4 2023.

Royal Bank of Canada first reported a position in DARE in Q4 2014 and has held it in 21 quarters since. The position peaked at $26K in Q1 2015. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • Royal Bank of Canada held 59 shares of Dare Bioscience worth $0 as of Q1 2026.
  • Dare Bioscience was a new Royal Bank of Canada position in Q1 2026.
  • Dare Bioscience made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7223 holding.
  • Royal Bank of Canada first reported a position in Dare Bioscience in Q4 2014 and has held it in 21 quarters since.
  • Royal Bank of Canada's Dare Bioscience position peaked at $26K in Q1 2015.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.